Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination
NCT03490097
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis c
Metabolic Syndrome
Interventions
DRUG:
Simvastatin 10mg
DRUG:
sofosbuvir plus daclatasvir
Sponsor
Ain Shams University